Quick summary
Palmitoyl Hexapeptide-12 (Biopeptide EL) is a lipid-conjugated cosmetic peptide containing the VGVAPG elastin fragment sequence. It stimulates elastin and collagen synthesis in fibroblasts for anti-aging applications, with the palmitoyl chain enhancing skin penetration.
Overview
Palmitoyl Hexapeptide-12 (also marketed as Biopeptide EL) is a lipid-conjugated hexapeptide used in cosmetic formulations. The palmitoyl group enhances skin penetration and lipophilicity. The VGVAPG sequence corresponds to a fragment of elastin and is thought to stimulate elastin and collagen synthesis in dermal fibroblasts, supporting skin elasticity and anti-aging applications.
Mechanism of action
The VGVAPG elastin peptide sequence acts on fibroblast receptors to stimulate extracellular matrix (ECM) production, including elastin, collagen, and fibronectin. The palmitoyl fatty acid chain improves skin penetration through the stratum corneum and enables incorporation into lipid bilayer-based delivery systems. The combination mimics the activity of natural elastin degradation products that signal dermal repair, promoting matrix synthesis and potentially reducing the appearance of fine lines and loss of elasticity.
Dosing protocols
| Purpose | Route | Dosage | Frequency | Notes |
|---|---|---|---|---|
| anti-aging skin care | topical | 2–10 % (w/v in formulation) | once to twice daily application |
Dosing information is for educational purposes only. Consult a qualified healthcare professional before using any peptide.
Research summary
In vitro studies have shown Palmitoyl Hexapeptide-12 stimulates elastin and collagen synthesis in fibroblast cultures. Small controlled cosmetic studies report improvements in skin firmness, elasticity, and reduced wrinkle appearance after several weeks of topical application. Clinical evidence is limited to industry-sponsored studies with small sample sizes. It is widely used in premium anti-aging serums and creams as a complement to peptides such as Matrixyl (Palmitoyl Pentapeptide-4).[1][2][3][4]
Evidence grading
Each claimed benefit is graded by the strength of available evidence. Grades reflect study quality, not effect size.
Strong = multiple RCTs · Moderate = limited trials or observational · Preliminary = animal or in vitro only · Insufficient = anecdotal or no published data
Side effects
Side effects vary by individual. This is not an exhaustive list. Report unusual symptoms to a healthcare professional.
Common stacks
Peptides commonly paired with Palmitoyl Hexapeptide-12 for synergistic effects.
Legal status
Palmitoyl Hexapeptide-12 is an OTC cosmetic ingredient regulated under cosmetics law (not as a drug). No prescription required. FDA oversight applies only if drug claims are made.
Sourcing & access
Research compound
Palmitoyl Hexapeptide-12 is classified as a research compound. Regulatory status varies by jurisdiction. Always verify current legal status and source from vendors providing third-party certificates of analysis (COA).
Frequently asked questions
Palmitoyl Hexapeptide-12, also marketed as Biopeptide EL, is a cosmetic peptide consisting of a palmitoyl fatty acid chain conjugated to the VGVAPG hexapeptide sequence derived from elastin. It is used in anti-aging serums and creams to improve skin elasticity.
The VGVAPG elastin sequence acts on fibroblast receptors to stimulate extracellular matrix production including elastin, collagen, and fibronectin. The palmitoyl fatty acid chain improves penetration through the stratum corneum, mimicking natural elastin degradation products that signal dermal repair.
Palmitoyl Hexapeptide-12 is generally well-tolerated as a topical cosmetic ingredient, with only rare contact sensitivity reported in use. It is regulated under cosmetics law rather than as a drug, requires no prescription, and FDA oversight applies only if the formulation makes specific drug claims beyond typical cosmetic marketing language.
Palmitoyl Hexapeptide-12 is found in premium anti-aging serums and creams at typical concentrations of 2–10% of the formulation, often combined with complementary matrix peptides such as Matrixyl (Palmitoyl Pentapeptide-4) for comprehensive ECM stimulation and Argireline (Acetyl Hexapeptide-3) for expression-line softening in layered anti-aging regimens applied once or twice daily.
Research references
- Palmitoyl hexapeptide-12 stimulates collagen and hyaluronic acid synthesis in skinPubMed
- Signal peptides in anti-aging cosmetics: mechanistic insightsPubMed
- Palmitoyl peptides in cosmetics: evidence for dermal matrix stimulationPubMed
- Topical cosmeceutical peptides: clinical outcomes in photoaged skinPubMed